NKGen Biotech: Funding, Investors & Team (Oct 2026)
NKGen Biotech, Inc. is a biotechnology company in the clinical stage that specializes in creating and selling advanced therapies using autologous, allogeneic, and CAR-NK Natural Killer (NK) cells. With unique technologies for expanding and activating cells, as well as advanced manufacturing capabilities, NKGen Biotech can multiply natural killer cells indefinitely and increase their ability to destroy harmful cells.
NKGen Biotech has raised $9.7M across 3 funding rounds on record, the most recent an undisclosed round of $2.0M announced in Jul 2025.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NKGen Biotech Company Profile and Key Stats
Latest funding round on record: Jul 2025.
NKGen Biotech Funding Rounds
NKGen Biotech raised $5.0M in an undisclosed round announced in Apr 2024.
1.1 years later, an undisclosed round of $2.7M was announced in May 2025.
2 months later, an undisclosed round of $2.0M was announced in Jul 2025.
NKGen Biotech Founders and Leadership Team
No contact details are on record for this team yet.
NKGen Biotech Funding Compared to Other Biotechnology Startups
NKGen Biotech's latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NKGen Biotech in Biotechnology and Santa Ana
Companies Similar to NKGen Biotech
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
NKGen Biotech Funding FAQs
What does NKGen Biotech do?
NKGen Biotech, Inc. is a biotechnology company in the clinical stage that specializes in creating and selling advanced therapies using autologous, allogeneic, and CAR-NK Natural Killer (NK) cells. With unique technologies for expanding and activating cells, as well as advanced manufacturing capabilities, NKGen Biotech can multiply natural killer cells indefinitely and increase their ability to destroy harmful cells.
How much funding has NKGen Biotech raised?
NKGen Biotech has raised $9.7M across 3 rounds on record. The most recent is an undisclosed round of $2.0M announced in Jul 2025.
When did NKGen Biotech last raise funding?
NKGen Biotech's most recent funding round on record is an undisclosed round of $2.0M, announced in Jul 2025.
Who founded NKGen Biotech?
FundedIQ lists Sangwoo Park (Founder) at NKGen Biotech.
Where is NKGen Biotech headquartered?
NKGen Biotech is based in Santa Ana, California, United States.
How many employees does NKGen Biotech have?
NKGen Biotech is in the 51-100 employee band.
How does NKGen Biotech's funding compare to other Biotechnology startups?
NKGen Biotech's latest round of $2.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's NKGen Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NKGen Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.